Published online Aug 16, 2016. doi: 10.12998/wjcc.v4.i8.233
Peer-review started: February 23, 2016
First decision: March 25, 2016
Revised: April 15, 2016
Accepted: June 14, 2016
Article in press: June 16, 2016
Published online: August 16, 2016
Processing time: 172 Days and 20.2 Hours
Thoracic endovascular aortic repair for thoracic aortic aneurysms is an accepted alternative to open surgery, especially in patients with significant comorbidities. The procedure itself has a low risk of complications and fistulas to surrounding organs are rarely reported. An 86-year-old patient was admitted to our hospital with gastro intestinal (GI) bleeding and a suspected aortoesophageal fistula. Eight months prior, the patient had undergone a stent graft repair of a mycotic thoracic aneurysm. Computerized tomography angiography and upper GI endoscopy confirmed an aortoesophageal fistula, which was treated by esophageal stenting. With early recognition, esophageal stenting may have a role in the initial emergency control of bleeding from and palliation of aortoesophageal fistula.
Core tip: Thoracic endovascular aortic repair (TEVAR) for thoracic aortic aneurysms is an accepted alternative to open surgery, especially in patients with significant comorbidities. The procedure itself has a low risk of complications and fistulas to surrounding organs are rarely reported. Aortoesophageal fistula post-TEVAR is a very rare entity; however, it is a devastating and usually fatal condition. Treatment options are very restricted, as these patients are often not candidates for complex surgery. We consider the placement of a covered self-expanding esophageal stent to be useful in the management of secondary aortoesophageal fistula after TEVAR to prevent re-bleeding in the fragile patient.
